Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: leucocyte elastase inhibitors - Dainippon Sumitomo Pharma

Next Previous
X
Search
Drug Profile

Research programme: leucocyte elastase inhibitors - Dainippon Sumitomo Pharma

Alternative Names: BL-3879; BL-5160; HNE inhibitors research programme - Dainippon Pharmaceutical; Human neutrophil elastase inhibitors research programme - Dainippon Pharmaceutical; Leucocyte elastase inhibitors research programme - Dainippon Pharmaceutical; Research programme: HNE inhibitors - Dainippon Pharmaceutical; Research programme: human neutrophil elastase inhibitors - Dainippon Pharmaceutical

Latest Information Update: 08 Feb 2008

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dainippon Sumitomo Pharma
  • Class
  • Mechanism of Action Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Chronic obstructive pulmonary disease

Most Recent Events

  • 08 Feb 2008 Discontinued - Preclinical for Chronic obstructive pulmonary disease in Japan (PO)
  • 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma
  • 23 Sep 2005 Preclinical trials in Chronic obstructive pulmonary disease in Japan (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top